RYTM
RHYTHM PHARMACEUTICALS, INC.
+1.46 (+1.49%)99.47USD287K成交股數6.8B市值–本益比(近四季)28.6股價營收比+46.9%營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 71.3M+47% | 60.1M+84% | 57.3M+72% | 51.3M+76% | 48.5M+87% | 32.7M+35% | 33.3M+48% | 29.1M+51% | 26.0M | 24.2M | 22.5M | 19.2M |
| 營業成本 | 8.9M | 7.2M | 4.8M | 5.5M | 5.5M | 3.6M | 3.8M | 2.9M | 2.8M | 3.2M | 2.4M | 2.2M |
| 毛利 | 62.3M+45% | 53.0M+82% | 52.5M+78% | 45.8M+75% | 43.0M+85% | 29.1M+38% | 29.4M+46% | 26.1M+54% | 23.2M | 21.0M | 20.1M | 17.0M |
| 毛利率 | 87.5% | 88.1% | 91.6% | 89.3% | 88.6% | 88.8% | 88.5% | 89.9% | 89.2% | 86.7% | 89.3% | 88.4% |
| 研發費用 | 43.4M | 41.7M | 42.0M | 46.0M | 42.3M | 37.0M | 37.9M | 30.2M | 129M | 29.9M | 33.6M | 33.5M |
| 銷售管理費用 | 67.4M | 63.6M | 57.5M | 52.4M | 45.9M | 39.1M | 35.4M | 36.4M | 34.4M | 32.4M | 30.5M | 30.0M |
| 營業利益 | −48.6M+7% | −52.4M+11% | −47.1M+7% | −52.7M+30% | −45.3M-68% | −47.0M+14% | −43.9M-0% | −40.5M-13% | −140M | −41.3M | −44.0M | −46.6M |
| 營業利益率 | -68.1% | -87.1% | -82.2% | -102.6% | -93.4% | -143.7% | -132.0% | -139.2% | -538.7% | -170.3% | -195.3% | -242.5% |
| 稅後淨利 | −49.3M+6% | −55.6M+12% | 149M-441% | −52.9M+64% | −46.6M-67% | −49.5M-135% | −43.6M-1% | −32.3M-31% | −141M | 143M | −44.2M | −46.7M |
| 淨利率 | -69.2% | -92.6% | 260.0% | -103.1% | -96.1% | -151.4% | -131.2% | -110.9% | -544.4% | 589.5% | -196.2% | -243.0% |
| 稀釋 EPS | -0.73-3% | -0.83+2% | -0.730% | -0.82+49% | -0.75-68% | -0.81+16% | -0.73-4% | -0.55-33% | -2.35 | -0.70 | -0.76 | -0.82 |
| 稀釋股數 | 68.6M | 68.0M | 65.0M | 66.3M | 63.7M | 63.1M | 61.2M | 61.0M | 60.1M | 57.7M | 57.9M | 56.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 65.6M | 62.1M | 54.3M | 52.1M | 136M | 106M | 47.5M | 162M | 53.4M | 60.1M | 64.6M | 116M |
| 應收帳款 | 40.4M | 34.2M | 26.1M | 33.0M | 26.1M | 17.8M | 19.3M | 17.6M | 14.7M | 14.9M | 14.5M | 13.8M |
| 存貨 | 30.5M | 28.7M | 25.8M | 22.1M | 18.9M | 19.3M | 13.9M | 12.0M | 8.5M | 8.6M | 7.8M | 6.2M |
| 總資產 | 437M | 442M | 480M | 507M | 373M | 387M | 364M | 382M | 259M | 333M | 354M | 310M |
| 有息負債 | 93.4M | 98.3M | 101M | 103M | 106M | 108M | – | – | – | 106M | – | – |
| 總負債 | 220M | 205M | 210M | 211M | 239M | 224M | 211M | 202M | 197M | 163M | 157M | 128M |
| 股東權益 | 103M | 123M | 139M | 149M | −11.9M | 18.9M | 11.2M | 39.3M | 61.6M | 170M | 197M | 182M |
| 負債比 | 50.3% | 46.3% | 43.8% | 41.7% | 64.2% | 57.8% | 58.0% | 53.0% | 76.2% | 49.0% | 44.2% | 41.2% |
| 淨現金(現金 − 有息負債) | −27.8M | −36.2M | −46.6M | −51.3M | 29.6M | −1.8M | – | – | – | −46.1M | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −44.2M+10% | – | – | – | −40.4M | – | – | −40.7M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 190M
| Single Reportable | 190M | 100.0% | +45.8% |
|---|
產品／服務2025 年度 · 195M
| 產品 | 195M | 100.0% | +49.7% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 190M | +45.8% | −197K | -0.1% | -3.11 | −117M |
| FY2024 | 130M | +68.1% | −261K | -0.2% | -4.34 | −114M |
| FY2023 | 77.4M | +227.6% | −185K | -0.2% | -3.20 | −136M |
| FY2022 | 23.6M | +649.5% | −181K | -0.8% | -3.47 | −174M |
| FY2021 | 3.2M | – | −70K | -2.2% | -1.40 | −146M |
| FY2020 | 0.00 | – | −134M | –% | -3.04 | −122M |
| FY2019 | 0.00 | – | −141M | –% | -3.86 | −126M |
| FY2018 | 0.00 | – | −74.1M | –% | -2.39 | −62.8M |